200
Participants
Start Date
March 1, 2023
Primary Completion Date
May 31, 2024
Study Completion Date
August 31, 2025
Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
"1. Azacytidine (75 mg/m2/day, days 1 to 7).~2. Cytarabine (75-100 mg/m2 bid, days 1 to 5).~3. Aclacinomycin(20 mg/day, days 1,3,5).~4. Chidamide (30 mg/day , days 1,4,8,11).~5. Venetoclax (400 mg/day, days 1 to 14,Combined with posaconazole reduced to 100 mg/day,Combined with voriconazole reduced to 200 mg/day ).~6. Granulocyte colony-stimulating factor (300 μg/day, day 0 until agranulocytosis recovery)"
"3+7"
"IA regimen:~1. Idarubicin (8-10 mg/m2) for 3 days .~2. Cytarabine (75-100mg/m2, every 12 hrs) for 7 days.~DA regimen:~1. Daunorubicin(60 mg/m2) for 3 days.~2. Cytarabine (75-100mg/m2, every 12 hrs) for 7 days."
RECRUITING
Chinese PLA General Hospital, Beijing
940 Hospital of the People's Liberation Army Joint Logistic Support Force
OTHER
The General Hospital of Western Theater Command
OTHER
The General Hospital of Northern Theater Command
OTHER
The 960th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army
UNKNOWN
Air Force Military Medical University, China
OTHER
Yantai Yuhuangding Hospital
OTHER
People's Liberation Army (PLA) Strategic Support Force Characteristic Medical Center
UNKNOWN
First Hospital of China Medical University
OTHER
Chinese PLA General Hospital
OTHER